Lv41
460 积分 2023-04-06 加入
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-related Macular Degeneration: A Phase 3 Randomized Trial
3小时前
待确认
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
3小时前
已完结
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
5个月前
已完结
Review on the immunotherapy strategies against metastatic colorectal carcinoma
5个月前
已完结
Review on the immunotherapy strategies against metastatic colorectal carcinoma
5个月前
已关闭
[Chinese national guideline on diagnosis and management of cough(2021)]
5个月前
已完结
Zevorcabtagene Autoleucel: First Approval
6个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
7个月前
已完结
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
7个月前
已完结
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non–Gene-edited Allogeneic CAR T-Cell Therapy
7个月前
已完结
皖公网安备34019202002308
